4333 A Phase 3 Randomized Double Blind Placebo Controlled Study Of Bion 1301 In Adults With Iga Nephropathy
Work
Year: 2023
Type: article
Abstract: Background and Aims IgA nephropathy (IgAN) is the leading cause of primary glomerulonephritis and has limited treatment options, especially for high-risk patients. Approximately 30-45% of IgAN patien... more
Institutions UNSW Sydney, University of Leicester, Columbia University Irving Medical Center, University of Alabama at Birmingham, Hospital Británico de Buenos Aires +1 more
Cites:
Cited by: 1
Related to: 10
FWCI: 0.451
Citation percentile (by year/subfield): 55.12
Subfield: Nephrology
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: bronze